<p>药明康德公司（NYSE:MOH - 获取免费报告）在覆盖该公司的十五位分析师中获得了 “持有” 的平均推荐，Marketbeat 报告称。九位投资分析师对该股票给予了持有评级，六位分析师则给予了买入评级。在过去一年中，对该股票发布评级的分析师的平均一年价格目标为 365.38 美元。</p>
<p>获取 <strong>Molina Healthcare</strong> 警报：</p>
<ul>
<li>3 只在市场动荡中表现良好的健康保险股票</li>
</ul>
<p>几位股票研究分析师最近对 MOH 股票发表了看法。巴克莱将药明康德的价格目标从 339.00 美元上调至 362.00 美元，并在 4 月 25 日的报告中给予该股票 “等权重” 评级。华尔街禅在 4 月 11 日的报告中将药明康德的评级从 “持有” 上调至 “买入”。古根海姆在 4 月 9 日的研究报告中开始覆盖药明康德。他们对该股票给予了 “中性” 评级。斯蒂芬斯在 2 月 6 日的研究报告中重新发布了 “等权重” 评级，并对药明康德的股票设定了 345.00 美元的价格目标。最后，Truist Financial 在 4 月 11 日的研究报告中将药明康德的价格目标从 340.00 美元上调至 400.00 美元，并给予该股票 “买入” 评级。</p>
<p><strong>阅读我们关于药明康德的最新研究报告</strong></p>
<h2>药明康德价格表现</h2>
<ul>
<li>这 3 只医疗股票的势头正在增强</li>
</ul>
<p>NYSE:MOH 在周五开盘价为 304.83 美元。该公司的流动比率为 1.62，速动比率为 1.62，债务与股本比率为 0.69。该公司的市值为 165.2 亿美元，市盈率为 14.92，市盈增长比率为 1.06，贝塔值为 0.63。药明康德的 12 个月低点为 262.32 美元，12 个月高点为 365.23 美元。该公司的 50 日移动平均线为 324.45 美元，200 日移动平均线为 307.96 美元。</p>
<p>药明康德（NYSE:MOH - 获取免费报告）最近在 4 月 23 日发布了季度财报。该公司报告每股收益（EPS）为 6.08 美元，超出分析师一致预期的 5.96 美元，超出幅度为 0.12 美元。药明康德的股本回报率为 28.13%，净利润率为 2.90%。该公司季度收入为 111.5 亿美元，而一致预期为 108.6 亿美元。在去年同期，该公司每股收益为 5.73 美元。与去年同期相比，该公司的季度收入增长了 12.2%。平均而言，股票研究分析师预测药明康德在当前财年将发布每股收益 24.4 美元。</p>
<h2>药明康德的内部买卖</h2>
<ul>
<li>医疗保险优势成本激增：这两家保险公司如何蓬勃发展</li>
</ul>
<p>在其他新闻中，董事理查德·M·沙皮罗在 4 月 29 日的交易中出售了 669 股该公司的股票。该股票以平均 320.50 美元的价格出售，总价值为 214,414.50 美元。交易完成后，该董事现在拥有 11,244 股公司股票，价值 3,603,702 美元。这笔交易代表了他们持股的 5.62% 的减少。该交易已在向证券交易委员会提交的文件中披露，文件可通过此超链接获取。此外，董事史蒂文·J·奥兰多在 3 月 3 日的交易中出售了 1,000 股该公司的股票。该股票以平均 301.33 美元的价格出售，总价值为 301,330.00 美元。交易完成后，该董事现在拥有 17,375 股公司股票，价值 5,235,608.75 美元。这笔交易代表了他们持股的 5.44% 的减少。该销售的披露信息可以在这里找到。在过去 90 天内，内部人士已出售 89,169 股公司股票，价值 28,520,995 美元。当前 1.26% 的股票由公司内部人士持有。</p>
<h2>对药明康德的对冲基金看法</h2>
<p>对冲基金和其他机构投资者最近增加或减少了对该公司的持股。罗斯柴尔德投资公司在第一季度将其在药明康德的持股增加了 126.3%。罗斯柴尔德投资公司现在拥有 86 股公司股票，价值 28,000 美元，此前在上个季度增持了 48 股。锡安银行国家协会 UT 在第一季度获得了药明康德的新头寸，价值约 29,000 美元。殖民信托公司 SC 在第四季度将其在药明康德的持股增加了 930.0%。殖民信托公司 SC 现在拥有 103 股公司股票，价值 30,000 美元，此前在该期间增持了 93 股。德塞雷特互助福利管理公司在第一季度将其在药明康德的持股增加了 60.7%。德塞雷特互助福利管理公司现在拥有 90 股公司股票，价值 30,000 美元，此前在该期间增持了 34 股。最后，Elequin Capital LP 在第一季度将其在药明康德的持股增加了 170.6%。Elequin Capital LP 现在拥有 92 股公司股票，价值 30,000 美元，此前在该期间增持了 58 股。对冲基金和其他机构投资者持有该公司 98.50% 的股票。</p>
<h2>关于药明康德</h2>
<p>（获取免费报告）</p>
<p>药明康德公司为低收入家庭和个人提供管理医疗服务，涵盖医疗补助和医疗保险项目以及州保险市场。它分为四个部门：医疗补助、医疗保险、市场和其他。该公司在 19 个州提供服务。该公司成立于 1980 年，总部位于加利福尼亚州长滩。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票，而非 Molina 医疗</li>
<li>三只值得购买和持有的医疗股</li>
<li>Trade Desk 驳斥批评者；复苏看似将继续</li>
<li>做空 - 利弊分析</li>
<li>Booz Allen Hamilton 财报：BAH 股票的三个看涨信号</li>
<li>加拿大债券市场假期：如何投资和交易</li>
<li>这些 ETF 提供了轻松接触不断增长的国际市场的机会</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1PSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1PSA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 在 Molina 医疗吗？</h2>
<p>在考虑 Molina 医疗之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Molina 医疗并不在名单上。</p>
<p>尽管 Molina 医疗目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

Molina医疗

<p>Molina Healthcare, Inc.（纽约证券交易所代码：MOH）获得了 15 位分析师的平均评级为 “持有”，其中 9 位分析师持有该股票，6 位分析师买入。平均目标价为 365.38 美元。最近的评级包括巴克莱将目标价上调至 362.00 美元，Truist Financial 将其上调至 400.00 美元。该公司报告每股收益为 6.08 美元，超出预期，营收为 111.5 亿美元，同比增长 12.2%。内部交易显示持股比例下降，内部人士持有 1.26% 的股票。对冲基金也调整了在该公司的持股</p>

<p>Molina Healthcare, Inc. (NYSE:MOH - Get Free Report) has received an average recommendation of &#34;Hold&#34; from the fifteen analysts that are covering the company, Marketbeat reports. Nine investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $365.38.</p>
<div class="lb-trans"><p>药明康德公司（NYSE:MOH - 获取免费报告）在覆盖该公司的十五位分析师中获得了 “持有” 的平均推荐，Marketbeat 报告称。九位投资分析师对该股票给予了持有评级，六位分析师则给予了买入评级。在过去一年中，对该股票发布评级的分析师的平均一年价格目标为 365.38 美元。</p>
</div><p>Get <strong>Molina Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Molina Healthcare</strong> 警报：</p>
</div><ul>
<li>3 Health Insurance Stocks Holding Green in Market Turmoil</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只在市场动荡中表现良好的健康保险股票</li>
</ul>
</div><p>Several equities research analysts have recently weighed in on MOH shares. Barclays increased their price target on Molina Healthcare from $339.00 to $362.00 and gave the stock an &#34;equal weight&#34; rating in a report on Friday, April 25th. Wall Street Zen upgraded Molina Healthcare from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a report on Friday, April 11th. Guggenheim began coverage on Molina Healthcare in a research note on Wednesday, April 9th. They issued a &#34;neutral&#34; rating on the stock. Stephens reissued an &#34;equal weight&#34; rating and issued a $345.00 price objective on shares of Molina Healthcare in a research note on Thursday, February 6th. Finally, Truist Financial increased their price objective on Molina Healthcare from $340.00 to $400.00 and gave the stock a &#34;buy&#34; rating in a research note on Friday, April 11th.</p>
<div class="lb-trans"><p>几位股票研究分析师最近对 MOH 股票发表了看法。巴克莱将药明康德的价格目标从 339.00 美元上调至 362.00 美元，并在 4 月 25 日的报告中给予该股票 “等权重” 评级。华尔街禅在 4 月 11 日的报告中将药明康德的评级从 “持有” 上调至 “买入”。古根海姆在 4 月 9 日的研究报告中开始覆盖药明康德。他们对该股票给予了 “中性” 评级。斯蒂芬斯在 2 月 6 日的研究报告中重新发布了 “等权重” 评级，并对药明康德的股票设定了 345.00 美元的价格目标。最后，Truist Financial 在 4 月 11 日的研究报告中将药明康德的价格目标从 340.00 美元上调至 400.00 美元，并给予该股票 “买入” 评级。</p>
</div><p><strong>Read Our Latest Research Report on Molina Healthcare</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于药明康德的最新研究报告</strong></p>
</div><h2>Molina Healthcare Price Performance</h2>
<div class="lb-trans"><h2>药明康德价格表现</h2>
</div><ul>
<li>Momentum Grows for These 3 Healthcare Stocks</li>
</ul>
<div class="lb-trans"><ul>
<li>这 3 只医疗股票的势头正在增强</li>
</ul>
</div><p>NYSE:MOH opened at $304.83 on Friday. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $16.52 billion, a P/E ratio of 14.92, a P/E/G ratio of 1.06 and a beta of 0.63. Molina Healthcare has a 12 month low of $262.32 and a 12 month high of $365.23. The business's 50-day moving average is $324.45 and its 200 day moving average is $307.96.</p>
<div class="lb-trans"><p>NYSE:MOH 在周五开盘价为 304.83 美元。该公司的流动比率为 1.62，速动比率为 1.62，债务与股本比率为 0.69。该公司的市值为 165.2 亿美元，市盈率为 14.92，市盈增长比率为 1.06，贝塔值为 0.63。药明康德的 12 个月低点为 262.32 美元，12 个月高点为 365.23 美元。该公司的 50 日移动平均线为 324.45 美元，200 日移动平均线为 307.96 美元。</p>
</div><p>Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.96 by $0.12. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. The business had revenue of $11.15 billion for the quarter, compared to the consensus estimate of $10.86 billion. During the same period in the prior year, the business posted $5.73 earnings per share. The company's quarterly revenue was up 12.2% compared to the same quarter last year. On average, equities research analysts forecast that Molina Healthcare will post 24.4 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>药明康德（NYSE:MOH - 获取免费报告）最近在 4 月 23 日发布了季度财报。该公司报告每股收益（EPS）为 6.08 美元，超出分析师一致预期的 5.96 美元，超出幅度为 0.12 美元。药明康德的股本回报率为 28.13%，净利润率为 2.90%。该公司季度收入为 111.5 亿美元，而一致预期为 108.6 亿美元。在去年同期，该公司每股收益为 5.73 美元。与去年同期相比，该公司的季度收入增长了 12.2%。平均而言，股票研究分析师预测药明康德在当前财年将发布每股收益 24.4 美元。</p>
</div><h2>Insider Buying and Selling at Molina Healthcare</h2>
<div class="lb-trans"><h2>药明康德的内部买卖</h2>
</div><ul>
<li>Medicare Advantage Costs Surge: How These 2 Insurers Are Thriving</li>
</ul>
<div class="lb-trans"><ul>
<li>医疗保险优势成本激增：这两家保险公司如何蓬勃发展</li>
</ul>
</div><p>In other news, Director Richard M. Schapiro sold 669 shares of the firm's stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $320.50, for a total value of $214,414.50. Following the completion of the sale, the director now owns 11,244 shares of the company's stock, valued at $3,603,702. This trade represents a 5.62% decrease in their position. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available through this hyperlink. Also, Director Steven J. Orlando sold 1,000 shares of the firm's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total value of $301,330.00. Following the completion of the transaction, the director now owns 17,375 shares of the company's stock, valued at $5,235,608.75. This trade represents a 5.44% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 89,169 shares of company stock valued at $28,520,995. 1.26% of the stock is currently owned by corporate insiders.</p>
<div class="lb-trans"><p>在其他新闻中，董事理查德·M·沙皮罗在 4 月 29 日的交易中出售了 669 股该公司的股票。该股票以平均 320.50 美元的价格出售，总价值为 214,414.50 美元。交易完成后，该董事现在拥有 11,244 股公司股票，价值 3,603,702 美元。这笔交易代表了他们持股的 5.62% 的减少。该交易已在向证券交易委员会提交的文件中披露，文件可通过此超链接获取。此外，董事史蒂文·J·奥兰多在 3 月 3 日的交易中出售了 1,000 股该公司的股票。该股票以平均 301.33 美元的价格出售，总价值为 301,330.00 美元。交易完成后，该董事现在拥有 17,375 股公司股票，价值 5,235,608.75 美元。这笔交易代表了他们持股的 5.44% 的减少。该销售的披露信息可以在这里找到。在过去 90 天内，内部人士已出售 89,169 股公司股票，价值 28,520,995 美元。当前 1.26% 的股票由公司内部人士持有。</p>
</div><h2>Hedge Funds Weigh In On Molina Healthcare</h2>
<div class="lb-trans"><h2>对药明康德的对冲基金看法</h2>
</div><p>Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Rothschild Investment LLC raised its stake in Molina Healthcare by 126.3% in the 1st quarter. Rothschild Investment LLC now owns 86 shares of the company's stock worth $28,000 after acquiring an additional 48 shares during the last quarter. Zions Bancorporation National Association UT acquired a new position in shares of Molina Healthcare in the 1st quarter valued at about $29,000. Colonial Trust Co SC lifted its holdings in shares of Molina Healthcare by 930.0% in the 4th quarter. Colonial Trust Co SC now owns 103 shares of the company's stock valued at $30,000 after buying an additional 93 shares during the period. Deseret Mutual Benefit Administrators lifted its holdings in shares of Molina Healthcare by 60.7% in the 1st quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company's stock valued at $30,000 after buying an additional 34 shares during the period. Finally, Elequin Capital LP lifted its holdings in shares of Molina Healthcare by 170.6% in the 1st quarter. Elequin Capital LP now owns 92 shares of the company's stock valued at $30,000 after buying an additional 58 shares during the period. Hedge funds and other institutional investors own 98.50% of the company's stock.</p>
<div class="lb-trans"><p>对冲基金和其他机构投资者最近增加或减少了对该公司的持股。罗斯柴尔德投资公司在第一季度将其在药明康德的持股增加了 126.3%。罗斯柴尔德投资公司现在拥有 86 股公司股票，价值 28,000 美元，此前在上个季度增持了 48 股。锡安银行国家协会 UT 在第一季度获得了药明康德的新头寸，价值约 29,000 美元。殖民信托公司 SC 在第四季度将其在药明康德的持股增加了 930.0%。殖民信托公司 SC 现在拥有 103 股公司股票，价值 30,000 美元，此前在该期间增持了 93 股。德塞雷特互助福利管理公司在第一季度将其在药明康德的持股增加了 60.7%。德塞雷特互助福利管理公司现在拥有 90 股公司股票，价值 30,000 美元，此前在该期间增持了 34 股。最后，Elequin Capital LP 在第一季度将其在药明康德的持股增加了 170.6%。Elequin Capital LP 现在拥有 92 股公司股票，价值 30,000 美元，此前在该期间增持了 58 股。对冲基金和其他机构投资者持有该公司 98.50% 的股票。</p>
</div><h2>About Molina Healthcare</h2>
<div class="lb-trans"><h2>关于药明康德</h2>
</div><p>(Get Free Report</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.</p>
<div class="lb-trans"><p>药明康德公司为低收入家庭和个人提供管理医疗服务，涵盖医疗补助和医疗保险项目以及州保险市场。它分为四个部门：医疗补助、医疗保险、市场和其他。该公司在 19 个州提供服务。该公司成立于 1980 年，总部位于加利福尼亚州长滩。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Molina Healthcare</li>
<li>The Top 3 Healthcare Dividend Stocks to Buy and Hold</li>
<li>Trade Desk Silences Critics; Recovery Looks Poised to Continue</li>
<li>Short Selling - The Pros and Cons</li>
<li>Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH Stock</li>
<li>Canada Bond Market Holiday: How to Invest and Trade</li>
<li>These ETFs Provide Easy Exposure to Growing International Markets</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而非 Molina 医疗</li>
<li>三只值得购买和持有的医疗股</li>
<li>Trade Desk 驳斥批评者；复苏看似将继续</li>
<li>做空 - 利弊分析</li>
<li>Booz Allen Hamilton 财报：BAH 股票的三个看涨信号</li>
<li>加拿大债券市场假期：如何投资和交易</li>
<li>这些 ETF 提供了轻松接触不断增长的国际市场的机会</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1PSA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NYSE&amp;Symbol=MOH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Molina Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在 Molina 医疗吗？</h2>
</div><p>Before you consider Molina Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Molina 医疗之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Molina 医疗并不在名单上。</p>
</div><p>While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>尽管 Molina 医疗目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Molina 医疗公司（NYSE 代码：MOH）被分析师给予平均 “持有” 评级